Selfhacked
Selfhacked operates the SelfHacked science-based health content platform and the SelfDecode direct-to-consumer DNA analysis service, which uses AI-driven polygenic risk scoring to deliver personalized health reports to health-conscious consumers, practitioners, and genomic companies.
- Company typePrivate
- Founded2013
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What Selfhacked does
Selfhacked operates an integrated health content and personalized genomics platform centered on the SelfDecode brand. The company's flagship product, SelfDecode, is a direct-to-consumer DNA analysis service that applies AI-driven polygenic risk scoring to raw genetic data to generate personalized health reports, risk predictions, and lifestyle, supplement, and lab recommendations. Selfhacked itself functions as the company's content-led acquisition engine: a science-based blog and subdomain vertical sites (covering drugs, labs, supplements, genetics, and health conditions) publish peer-reviewed, expert-authored content designed to convert health-conscious readers into SelfDecode subscribers. The company serves three segments: health-conscious consumers seeking personalized genetic insights (primary); health professionals using SelfDecode Pro in clinical and wellness practices; and genomic companies leveraging SelfDecode Business (OmicsEdge) for testing, analysis, and research implementations.
The business model is a content-to-subscription DTC funnel: free, SEO-optimized articles and a 120,000+ subscriber newsletter feed top-of-funnel demand, while a self-serve subscription checkout on SelfDecode monetizes the back end. Distribution is digital-first and global via the website, with no disclosed app, API, or SDK integrations. The company is privately held, founder-owned and founder-led (CEO Joe Cohen), with no disclosed funding rounds, no institutional investors, no board composition data, and no headcount expansion signals beyond a stated 1-10 employee range. Reported traction includes 100,000+ users helped and earned-media coverage in Forbes, PBS, Scientific American, WebMD, STAT, CTV, ITV, Observer, Yahoo, and Genomeweb.
Operationally, Selfhacked runs a lean operation relative to the complexity of its stated offering. There are no disclosed regulatory clearances (FDA, CLIA, CAP), no certifications, and no patents or trademarks on file, which is material for a company making health-related predictions and recommendations in a regulated category. The technology stack and underlying polygenic risk scoring methodology are not described in detail, and there are no third-party benchmarks or peer-reviewed model validations disclosed. Pricing is not publicly disclosed. The company's principal assets are its content library, its user genetic dataset, and its brand reputation across health-conscious and biohacking audiences.
Selfhacked firmographics
Firmographics- Name
- Selfhacked
- Legal name
- SelfDecode
- Website
- https://selfhacked.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Selfhacked operates the SelfHacked science-based health content platform and the SelfDecode direct-to-consumer DNA analysis service, which uses AI-driven polygenic risk scoring to deliver personalized health reports to health-conscious consumers, practitioners, and genomic companies.
- Ownership category
- akta.pro rank
Where Selfhacked is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Selfhacked business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SelfDecode Subscription: SelfDecode operates as a subscription-based personalized health report service that enables users to obtain detailed information and reports based on their genome. The platform converts free blog readers to paid subscribers for comprehensive DNA analysis and health recommendations.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Selfhacked product offering
Product offeringCore offering
Selfhacked operates the SelfHacked science-based health content platform and SelfDecode, a direct-to-consumer DNA analysis service that uses AI-driven polygenic risk scoring to generate personalized health reports and recommendations from a user's genome. The blog drives organic acquisition while SelfDecode converts users into paying subscribers for ongoing genome-based health insights.
Product overview
SelfDecode operates as a platform with multiple integrated products: SelfDecode serves as the core personalized health report platform using AI-driven polygenic risk scoring for genome-based health insights; SelfDecode Pro extends this technology to health professionals; SelfDecode Business (OmicsEdge) provides enterprise genomic solutions; and SelfHacked Blog serves as the science-based content and educational platform.
Differentiator
Problem solved
Functional benefit
Brands
- SelfDecode: Personalized health report service that enables users to obtain detailed information and reports based on their genome, utilizing AI-driven polygenic risk scoring to produce accurate insights and health recommendations.
Products and services
- SelfDecode Direct-to-consumer DNA analysis subscription service that uses AI-driven polygenic risk scoring to generate personalized health reports and recommendations from a user's genome, targeted at health-conscious consumers seeking to optimize health through DNA and biomarker insights.
- SelfDecode Pro Separate SelfDecode offering targeted at health professionals and practitioners, providing them with tools and reports to support their practice and help patients interpret DNA-based health information.
- SelfDecode Business (OmicsEdge) Enterprise genomic platform (branded OmicsEdge) that enables genomic companies and research institutions to leverage SelfDecode's AI-driven polygenic risk scoring technology for accurate DNA testing, analysis, and research implementations.
Quantifiable outcome
- SelfDecode has helped over 100,000 people understand how to get healthier using their DNA and labs
Companies that use Selfhacked
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Selfhacked technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
Selfhacked partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SelfDecode ProminorSelfDecode Pro is a separate offering targeting health professionals, providing them with tools and insights to support their practice. This is an internal product line rather than an external partnership.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Selfhacked competitors and assessment
Company assessmentDirect peers
- DNAfit: Genetic-based fitness, nutrition, and wellness reports. Comparable on genetic-driven personalization in health/wellness categories.
- 23andMe: Direct-to-consumer DNA testing and personalized health/predisposition reports. Closest analog by category (DTC genomics with subscription health reports) and primary competitive threat, though at vastly larger scale.
- Viome: Subscription-based personalized health recommendations from microbiome and other biomarker testing. Comparable AI-driven recommendation engine and DTC subscription model.
- Ancestry: DTC DNA testing leader with large genetic database and health/traits reports. Comparable on direct-to-consumer DNA analysis, differing on genealogy-first positioning.
- Nebula Genomics: Whole-genome sequencing with privacy-preserving analysis and personalized reports. Comparable on AI-driven genomic analysis and D2C delivery, with stronger privacy/whole-genome positioning.
- Color Genomics: Clinical-grade genetic testing with population health and enterprise offerings. Comparable B2B genomic solutions lane adjacent to SelfDecode's OmicsEdge.
- InsideTracker: Personalized health and longevity platform combining blood biomarker and DNA analysis with actionable recommendations. Closely comparable value proposition to SelfDecode, with overlap in genetic + lab-based personalization.
- MyHeritage DNA: DTC DNA testing with health and ethnic-ancestry reports. Comparable on D2C DNA analysis subscription model, with global consumer reach.
Emerging players
- Genomelink: Personal genetic data platform with trait and wellness reports powered by raw DNA data. Comparable on AI-driven trait/wellness personalization from genetic data.
- SelfDecode (Sano Genetics-style wellness genomics): Wellness/prevention-focused genetic testing with consumer reports. Comparable on personalized genetic health insights, with a research-recruitment angle.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Selfhacked social profiles
Digital presenceSelfhacked financial estimates
Financial estimateRevenue estimate
Valuation estimate
Selfhacked leadership team
Management profileNumber of profiles
Profiles1 record
Selfhacked funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Selfhacked M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Selfhacked
What does Selfhacked do?
Selfhacked operates the SelfHacked science-based health content platform and SelfDecode, a direct-to-consumer DNA analysis service that uses AI-driven polygenic risk scoring to generate personalized health reports and recommendations from a user's genome. The blog drives organic acquisition while SelfDecode converts users into paying subscribers for ongoing genome-based health insights.
Is Selfhacked a public or private company?
Selfhacked is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Selfhacked founded?
Selfhacked was founded in 2013. It employs 1 to 10 people.
Where is Selfhacked based?
Selfhacked is headquartered in New York, United States, in the North America region.
How does Selfhacked make money?
One revenue line is on record: selfDecode Subscription.
Who are Selfhacked's main competitors?
Direct peers on record are DNAfit, 23andMe, Viome, Ancestry, Nebula Genomics, Color Genomics, InsideTracker and MyHeritage DNA. Emerging players are Genomelink and SelfDecode (Sano Genetics-style wellness genomics).
Does Selfhacked have an API?
No public API is recorded for Selfhacked.